Trial
NCT02423148
Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Beth Israel Deaconess Medical Center; Akorn, Inc.
Condition
Lung Cancer
Intervention
Indocyanine green (ICG)
Why stopped
Co-investigator left facility. Decided not to enroll patients therefore.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-16